About Us

Our team is comprised of a group of senior managers with more than 20 years of expertise in defining reimbursement strategy and business planning.  We are uniquely qualified to provide information and services for emerging medical innovations and the biocapital resources that fund them. 

Whether you are an investor needing to understand the reimbursement ramifications surrounding the product you are investing in, or an executive who needs to ensure your managed market success, we can help. Investing in or managing a life science or biotech business is not just about the science, it is also about the business and the impact reimbursement issues can have on the bottom line.